Cargando…
Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy
β-alanine is an amino acid that, when combined with histidine, forms the dipeptide carnosine within skeletal muscle. Carnosine and β-alanine each have multiple purposes within the human body; this review focuses on their roles as ergogenic aids to exercise performance and suggests how to best quanti...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407982/ https://www.ncbi.nlm.nih.gov/pubmed/22852051 http://dx.doi.org/10.3390/nu4070585 |
_version_ | 1782239415659134976 |
---|---|
author | Caruso, John Charles, Jessica Unruh, Kayla Giebel, Rachel Learmonth, Lexis Potter, William |
author_facet | Caruso, John Charles, Jessica Unruh, Kayla Giebel, Rachel Learmonth, Lexis Potter, William |
author_sort | Caruso, John |
collection | PubMed |
description | β-alanine is an amino acid that, when combined with histidine, forms the dipeptide carnosine within skeletal muscle. Carnosine and β-alanine each have multiple purposes within the human body; this review focuses on their roles as ergogenic aids to exercise performance and suggests how to best quantify the former’s merits as a buffer. Carnosine normally makes a small contribution to a cell’s total buffer capacity; yet β-alanine supplementation raises intracellular carnosine concentrations that in turn improve a muscle’s ability to buffer protons. Numerous studies assessed the impact of oral β-alanine intake on muscle carnosine levels and exercise performance. β-alanine may best act as an ergogenic aid when metabolic acidosis is the primary factor for compromised exercise performance. Blood lactate kinetics, whereby the concentration of the metabolite is measured as it enters and leaves the vasculature over time, affords the best opportunity to assess the merits of β-alanine supplementation’s ergogenic effect. Optimal β-alanine dosages have not been determined for persons of different ages, genders and nutritional/health conditions. Doses as high as 6.4 g day(−1), for ten weeks have been administered to healthy subjects. Paraesthesia is to date the only side effect from oral β-alanine ingestion. The severity and duration of paraesthesia episodes are dose-dependent. It may be unwise for persons with a history of paraesthesia to ingest β-alanine. As for any supplement, caution should be exercised with β-alanine supplementation. |
format | Online Article Text |
id | pubmed-3407982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-34079822012-07-31 Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy Caruso, John Charles, Jessica Unruh, Kayla Giebel, Rachel Learmonth, Lexis Potter, William Nutrients Review β-alanine is an amino acid that, when combined with histidine, forms the dipeptide carnosine within skeletal muscle. Carnosine and β-alanine each have multiple purposes within the human body; this review focuses on their roles as ergogenic aids to exercise performance and suggests how to best quantify the former’s merits as a buffer. Carnosine normally makes a small contribution to a cell’s total buffer capacity; yet β-alanine supplementation raises intracellular carnosine concentrations that in turn improve a muscle’s ability to buffer protons. Numerous studies assessed the impact of oral β-alanine intake on muscle carnosine levels and exercise performance. β-alanine may best act as an ergogenic aid when metabolic acidosis is the primary factor for compromised exercise performance. Blood lactate kinetics, whereby the concentration of the metabolite is measured as it enters and leaves the vasculature over time, affords the best opportunity to assess the merits of β-alanine supplementation’s ergogenic effect. Optimal β-alanine dosages have not been determined for persons of different ages, genders and nutritional/health conditions. Doses as high as 6.4 g day(−1), for ten weeks have been administered to healthy subjects. Paraesthesia is to date the only side effect from oral β-alanine ingestion. The severity and duration of paraesthesia episodes are dose-dependent. It may be unwise for persons with a history of paraesthesia to ingest β-alanine. As for any supplement, caution should be exercised with β-alanine supplementation. MDPI 2012-06-26 /pmc/articles/PMC3407982/ /pubmed/22852051 http://dx.doi.org/10.3390/nu4070585 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Caruso, John Charles, Jessica Unruh, Kayla Giebel, Rachel Learmonth, Lexis Potter, William Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy |
title | Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy |
title_full | Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy |
title_fullStr | Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy |
title_full_unstemmed | Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy |
title_short | Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy |
title_sort | ergogenic effects of β-alanine and carnosine: proposed future research to quantify their efficacy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407982/ https://www.ncbi.nlm.nih.gov/pubmed/22852051 http://dx.doi.org/10.3390/nu4070585 |
work_keys_str_mv | AT carusojohn ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy AT charlesjessica ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy AT unruhkayla ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy AT giebelrachel ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy AT learmonthlexis ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy AT potterwilliam ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy |